We have located links that may give you full text access.
Understanding Membrane Protein Drug Targets in Computational Perspective.
Current Drug Targets 2018 December 5
Membrane proteins play a crucial physiological role in vivo and are the major category of drug targets for pharmaceuticals. The research on membrane protein is a significant part in drug discovery due to a membrane protein can be regarded as a vital hub while most drug effect by drug-target interaction and the biological process can be supposed as a cycled network. In this review, typical membrane protein targets are described, including GPCRs, transporters, ion channels. In addition, network servers and databases referring to the drug and target information as well as drug discovery data are concluded. Furthermore, we chiefly introduce the development and practice of modern medicines, particularly demonstrating a series of state-of-the-art computational models for prediction of drug-target interaction containing network-based approach and machine learning based approach as well as current achievements. Finally, we discuss the prospective orientation of drug repurposing and drug discovery as well as propose some improved framework in quantitative bioactivity data, created or improved predicted approaches, alternative understanding approaches of drugs bioactivity and their biological processes.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app